Advertising disclosure: Vital Review may earn a commission when you use some provider links on this page. This does not change the prices we record or our review methodology. Read our Advertising & Affiliate Disclosure.
Price data checked September 17, 2026. Tirzepatide prices are not directly comparable unless you also compare billing cadence, dose or formulation, whether medication is included, clinician fees, shipping, refill terms, and whether the product is an FDA-approved brand or a compounded prescription. This page separates those factors instead of ranking providers from one headline number.
How much does tirzepatide cost per month?
Among the online-provider plans we could verify with a clearly published standard month-to-month or monthly tirzepatide charge, current compounded-program references generally run from about $240 to $399 per month. Lower figures exist, but many are tied to annual commitments, microdose programs, introductory offers, or a separate eligibility pathway.
| Provider | Published tirzepatide price | Billing structure | What to check | Review |
|---|---|---|---|---|
| LevelsRx | From $240/month | Month-to-month subscription | Current listed compounded tirzepatide starting price. Clinical care, nutrition support and home delivery are bundled; confirm the active checkout price for the prescribed pathway. | LevelsRx review · Provider |
| bmiMD | $249 | One-month plan | Provider visit and shipping are listed as included. Lower monthly equivalents require prepaid multi-month plans. | bmiMD review · Provider |
| Lttl | $279 | Monthly reference | The same site also publishes an annual equivalent. Current checkout should be confirmed because retrieved price presentations have varied. | Lttl review · Provider |
| Enhanced | $299 | GLP-1/GIP pathway billed monthly | A separate product page advertises tirzepatide “starting at $129/mo,” so the qualifying pathway and final checkout amount matter. | Enhanced review · Provider |
| Fridays | $359 | Month-to-month compounded plan | Medication, consultation, care, supplies, shipping and ongoing support are listed as included. Annual-plan equivalents are lower. | Fridays review · Provider |
| Maximus Tribe | $359.99 | One-month plan | Lower monthly equivalents require longer commitments; multi-month plans have more restrictive early-exit terms. | Maximus Tribe review · Provider |
| Direct Meds | $399 on current product portal | Injectable tirzepatide | An official support article still lists $497 per 30-day bottle. Because the provider currently publishes both figures, confirm checkout before relying on either. | Direct Meds review · Provider |
These are provider price references, not personalized medical or checkout quotes. Prescription approval is not guaranteed, and compounded formulations can differ by pharmacy and prescription.
Lower tirzepatide prices often come with a qualification
A lower “per month” number can reflect annual prepayment, a microdose program, a limited introductory offer, or a price that applies only to a particular pathway. We list those separately because they are not automatically equivalent to a full month-to-month tirzepatide program.
| Provider / offer | Published lower figure | Qualification | Why it needs context |
|---|---|---|---|
| Enhanced | Starting at $129/month | Product-page starting price | A separate GLP-1/GIP pathway page lists $299 billed monthly, so the qualifying product, protocol and payment terms should be confirmed. |
| bmiMD | $179/month equivalent | 12-month prepaid plan, $2,148 total | The lower equivalent requires substantial prepayment and unused prepaid time has restricted refund treatment. |
| BetterMe Rx microdose | $185/month equivalent | 12-month microdose tirzepatide plan | This is explicitly a lower-dose microdose program, not a like-for-like comparison with every standard tirzepatide plan. Month-to-month microdose injection is listed from $235. |
| Lttl | $199/month equivalent | Annual plan billed $2,388 | The annual equivalent is financially different from the provider’s monthly price. |
| Fridays | $240/month equivalent | Annual plan, delivered monthly | The month-to-month compounded plan is currently listed at $359. |
| Maximus Tribe | $240/month equivalent | 12-month plan | The lower equivalent is tied to a longer commitment with restrictive early termination and refund terms. |
| Joi + Blokes | $249/month equivalent | $747 billed for three months | The supply is sold as a quarterly commitment rather than an independent $249 monthly purchase. |
What about $99 or $129 tirzepatide offers?
Some telehealth companies now advertise tirzepatide-related offers below $150 per month. For example, Enhanced currently advertises standard tirzepatide “starting at $129/mo” and a separate microdosed tirzepatide pathway “starting at $99/mo.” Those numbers are useful leads, but they do not by themselves establish the applicable dose, full payment term, renewal price, or whether the same pathway is comparable with a standard-dose monthly program. We therefore do not label the lowest headline as the “cheapest tirzepatide” without those details.
Zepbound self-pay cost in September 2026
FDA-approved Zepbound should be separated from compounded-provider pricing. LillyDirect currently publishes self-pay prices by dose and presentation for Zepbound.
| Zepbound option | Current self-pay reference | Important qualification |
|---|---|---|
| 2.5 mg KwikPen or vial | $299/month | Starting dose; self-pay eligibility and program terms apply. |
| 5 mg KwikPen or vial | $399/month | Self-pay eligibility and program terms apply. |
| 7.5 mg, 10 mg, 12.5 mg or 15 mg | $449/month | Journey Program pricing requires refill within 45 days. |
| Higher doses without the 45-day refill condition | $499 to $699/month regular price | Lilly lists $499 for 7.5 mg and $699 for 10 mg, 12.5 mg and 15 mg when the Journey Program refill condition is not met. |
Eligible commercially insured patients with Zepbound coverage may be able to pay as little as $25 for up to a three-month prescription under Lilly’s savings program, subject to eligibility, limits and terms. That savings-card figure should not be treated as the universal cash price.
What does Mounjaro cost?
Mounjaro also contains tirzepatide, but it is a separate branded prescription with a different approved use and should not be treated as interchangeable pricing for a weight-management program. Lilly currently lists a $1,112.16 list price for a 28-day supply. LillyDirect also advertises self-pay Mounjaro starting at $499/month. Eligible commercially insured patients with coverage may pay as little as $25 under the Mounjaro Savings Card; commercially insured patients without coverage may qualify for other savings terms. Actual out-of-pocket cost depends on insurance and eligibility.
Compounded tirzepatide has a different regulatory status
Many online-provider prices on this page refer to compounded tirzepatide rather than Zepbound or Mounjaro. Compounded drugs are not FDA-approved. FDA states that the national tirzepatide shortage is resolved, tirzepatide is not currently on the FDA drug shortage list, and compounders must meet the conditions of federal law rather than relying on shortage-based enforcement discretion. FDA also reminds providers that compounded products cannot be marketed as if they are FDA-approved generics or the same as approved products. See the FDA’s April 2026 compounding update and GLP-1 compounding concerns.
What should be included in a tirzepatide price comparison?
- Actual billing cadence: monthly, quarterly, six-month or annual payment.
- Formulation and pathway: standard injection, oral compounded product, microdose program, Zepbound or Mounjaro.
- Medication: whether the displayed fee includes the medication or only a care membership.
- Clinical care: consultation, follow-up, messaging and lab requirements.
- Shipping: included delivery versus separate pharmacy or delivery charges.
- Dose pricing: whether cost changes with dose or refill timing.
- Cancellation: how early renewal must be stopped and whether prepaid time is refundable.
- Pharmacy transparency: whether the provider identifies the dispensing pharmacy or network.
How Vital Review checks tirzepatide prices
We compare provider pricing pages, product pages, terms, cancellation policies, pharmacy disclosures and, where available, checkout pricing. We separate introductory and “starting at” offers from ongoing prices, and we do not convert a prepaid annual plan into a simple monthly price without also showing the commitment. Each provider review records its own last-verified date. Read our review methodology.
Tirzepatide cost FAQs
How much is tirzepatide without insurance?
There is no single cash price. In our current provider dataset, clearly published standard monthly compounded-program references run from about $240 to $399, while annual plans, microdose pathways and other offers can advertise lower monthly equivalents. FDA-approved Zepbound and Mounjaro have separate manufacturer pricing.
What is the cheapest tirzepatide online?
The lowest headline is not necessarily the lowest comparable total cost. A $99 or $129 offer may refer to a microdose or qualifying pathway, while a $179 or $199 figure may require annual prepayment. The useful comparison is the same formulation and service level, plus total commitment, care, shipping and cancellation terms.
How much does Zepbound cost without insurance?
LillyDirect currently lists Zepbound self-pay prices starting at $299/month for 2.5 mg and $399/month for 5 mg. Higher doses are listed at $449/month when the Journey Program refill condition is met, with higher regular prices when it is not.
Why do online tirzepatide prices vary so much?
Providers package medication and care differently, and some advertise annual-plan equivalents or lower-dose pathways rather than a standard month-to-month program. Dose, formulation, pharmacy, coaching, clinical follow-up and refill timing can all affect the displayed price.
Medical information notice: This page compares prices and service terms. It does not determine whether tirzepatide, a compounded formulation, Zepbound or Mounjaro is appropriate for an individual. Prescription decisions belong to a licensed healthcare professional.